Prof. Dr. Annkristin Heine
Institute of Experimental Immunology (IEI) & Medical Clinic III
annkristin.heine@ukbonn.de View member: Prof. Dr. Annkristin Heine
Cell death & disease
High salt diet (HSD) is known to reduce cancer growth in some tumor models, which has been attributed to tissue accumulation of sodium that enhances local anti-tumor immunity. Here, we show that a HSD inhibits melanoma growth independent of sodium accumulation and immune cells in skin and lung. Melanoma cells from mice on a HSD upregulated the metabolic inhibitor Tuberous sclerosis complex 2 (TSC2), causing metabolic shutdown despite nutrient availability. Furthermore, Microphthalmia-associated transcription factor (MITF), a crucial regulator of melanoma metabolism and differentiation, was upregulated, resulting in enhanced melanogenesis and cell cycle arrest. Thus, a HSD reversed the de-differentiation of melanoma cells and promoted their re-differentiation into a "normal" melanocytic state. These findings suggest that the anti-tumor effect of HSD may be tumor-specific and in some cases immune cell-independent.
© 2025. The Author(s).
PMID: 41422056
Institute of Experimental Immunology (IEI) & Medical Clinic III
annkristin.heine@ukbonn.de View member: Prof. Dr. Annkristin HeineInstitute of Experimental Immunology (IEI)
jbecker-gotot@uni-bonn.de View member: Dr. Janine Becker-GototLife & Medical Sciences Institute (LIMES)
cthiele@uni-bonn.de View member: Prof. Dr. Christoph ThieleInstitute of Clinical Chemistry & Clinical Pharmacology
cwilhelm@uni-bonn.de View member: Prof. Dr. Christoph WilhelmInstitute of Experimental Oncology
michael.hoelzel@ukbonn.de View member: Prof. Dr. Michael HölzelInstitute of Molecular Medicine and Experimental Immunology (IMMEI)
ckurts@uni-bonn.de View member: Prof. Dr. Christian Kurts